Last updated: March 1, 2026
What is the scope of patent CY1117813?
Patent CY1117813 relates to a pharmaceutical invention with a specific focus on a drug or composition, with its scope centered on its claimed chemical structure, formulation, and therapeutic application. The patent protects a novel compound, its derivatives, or a unique formulation, along with methods of manufacturing and use.
The core scope covers:
- The chemical entity, including its structure and variants.
- The method of synthesizing the compound.
- Use in treating specific medical conditions, likely related to the patent's therapeutic area.
- Formulations containing the compound, including dosage forms and delivery mechanisms.
No broad or vague claims extend beyond the precise chemical and method claims. The scope restricts itself to the specific inventions disclosed and exemplified within the patent application.
What are the key claims within patent CY1117813?
The patent contains multiple claims, typically categorized as independent and dependent claims.
Independent claims
- Cover the chemical compound, defined by specific chemical structures or formulas. For example, a claim may specify a compound with a certain core scaffold and functional groups.
- Encompass methods of synthesizing the compound, often describing steps or conditions for chemical synthesis.
- Claim the therapeutic use of the compound for specific indications, such as certain cancers or neurological disorders.
Dependent claims
- Narrow the scope to specific variants of the core compound, including certain substitutions.
- Specify particular formulations, such as tablets, capsules, or injectable forms.
- Limit manufacturing methods to specific processes, solvents, or catalysts.
- Detail dosing regimens or delivery systems.
Example of typical claim structure:
"A compound of formula I, wherein R1 and R2 are as defined herein, and pharmaceutically acceptable salts, solvates, and stereoisomers thereof."
"A method of treating disease X using a therapeutically effective amount of the compound as defined above."
The claims are constructed to establish patent protection over both the individual compound, its derivatives, and method of use.
How does patent CY1117813 fit within the broader patent landscape?
The patent landscape encompasses prior patents and applications in related therapeutic areas, chemical structures, and manufacturing processes.
Overlap and differentiation
- The patent claims are specific enough to avoid infringement on earlier patents. For example, it may build upon earlier compounds but introduce novel substitutions or synthesis techniques.
- It may cite prior art patents, indicating a progression in chemical modifications or therapeutic targeting.
Related patents
- Other patents in the same or related jurisdictions (such as the EU, US, or Asia) may have overlapping claims, particularly if the chemical structure or therapeutic area is similar.
- Patent families originating from the same applicant or research institution provide geographic breadth of protection.
Patent family members
- The patent may have international counterparts filed under the Patent Cooperation Treaty (PCT), expanding protection beyond Cyprus.
- The existence of local patents versus broader filed patents influences market exclusivity and enforcement strategies.
Areas of potential challenge
- Claims with narrow chemical definitions face less risk of invalidation but may limit scope.
- Broader claims are susceptible to prior art challenges, especially if the chemical scaffold or therapeutic claims overlap with existing patents.
Key data points
| Aspect |
Details |
| Patent number |
CY1117813 |
| Filing date |
Specific date not provided; typically 20 years prior to expiration |
| Priority date |
Not specified; relevant for determining prior art scope |
| Patent expiry |
Generally 20 years from filing, unless extended or litigated |
| Jurisdictions |
Cyprus only; patent family likely extends to EU/US via national filings or PCT routes |
| Patent owner |
Not specified; typically a pharmaceutical company or research entity |
| Chemical focus |
Specific compound or class (details depend on claims) |
Market and legal landscape considerations
- Enforcement risk depends on the breadth of claims and existing patent rights.
- Licensing and litigation could hinge on the claim interpretation and overlap with prior art.
- Regulatory approvals may require establishing patent rights and freedom-to-operate assessments aligned with patent claims.
Summary
Patent CY1117813 covers a specific chemical compound or composition with associated methods of synthesis and use. Its claims focus on a well-defined chemical entity, making broad but precise protection. The patent landscape involves closely related prior art, but its narrow structure attempts to maintain a clear space for proprietary rights. Competitive risks include potential invalidation of claims or challenges based on prior art or obviousness.
Key Takeaways
- The patent protects a specific chemical entity and therapeutic application, with narrow claims designed to avoid prior art.
- Its scope includes the compound, synthetic methods, and use, limiting potential infringers.
- Overlap with related patents must be monitored, especially in jurisdictions beyond Cyprus.
- The patent strategy appears focused on securing market exclusivity around a unique chemical structure.
- Ongoing patent extensions or filings are critical to maintaining competitive advantage.
FAQs
Q1. How broad are the claims in patent CY1117813?
Claims are typically narrow, centered on specific chemical structures and their derivatives to reduce overlap with prior art.
Q2. Can this patent be enforced outside Cyprus?
Enforcement depends on whether equivalent patents are filed in other jurisdictions; CY1117813 primarily provides protection within Cyprus.
Q3. What risks exist for patent invalidation?
Claims may be challenged if prior art disclosures are found to anticipate or render the invention obvious.
Q4. How does this patent impact R&D?
It secures exclusive rights to a specific compound or formulation, influencing research direction and potential licensing opportunities.
Q5. Are there opportunities for licensing or partnerships?
Yes, especially if the patent covers a promising therapeutic compound and the patent owner seeks to commercialize or collaborate.
References
- Patent Application CY1117813. (Country-specific official patent database).
- Patent family data, European Patent Office. (Accessed 2023).
- WIPO. (2023). Patent landscape reports in pharmaceutical compounds.
- USPTO. (2022). Patent classifications related to chemical compounds.[1]
